Zobrazeno 1 - 10
of 34
pro vyhledávání: '"59"'
Autor:
Bénédicte Gourieux, Bruno Michel, Fanny Reisz, Thierry Nai, Aurélie Reiter-Schatz, Marion Fourtage, Yasmine Nivoix, Yvon Ruch, François Danion, Julia Walther, Anne Sophie Belmas
Publikováno v:
European Journal of Hospital Pharmacy
Objective The aims of this study were to describe prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis (primary endpoint), then to characterise pharmaceutical interventions (PIs) target
Autor:
Rafael Hernandez, Itziar Ibarrondo, Saioa Domingo-Echaburu, Marian Solinis, Unax Lertxundi Etxebarria, Arantxa Isla, Itziar Palacios-Zabalza
Publikováno v:
Eur J Hosp Pharm
INTRODUCTION: Parkinson’s disease (PD) is considered to be the fastest growing neurological disorder in the world. Patients with PD are hospitalised more frequently, have longer admissions and experience more complications during hospitalisation th
Autor:
Gln ZAhreddine, Waldirce Inêz de Souza, C Avelar Ferreira, H Azevedo Guimarães, B Barreto Vianna, M Guatimosim Azevedo
Publikováno v:
European Journal of Hospital Pharmacy. 20:A48.2-A48
Background Drug interactions (DIs) occur when one drug affects the activity of another drug when both are administered together. This is clinically relevant as it may cause drug-related adverse events, and is generally preventable. [1–3] Purpose To
Publikováno v:
European Journal of Hospital Pharmacy. 20:A122.2-A123
Background Linezolid (LNZ) is an antibiotic indicated for the treatment of methicillin-resistant Gram-positive infections. Following recent unavailability of fosfomycin in France, local standards for the treatment of nosocomial meningitis and nosocom
Autor:
AC Viney, Mdr Gutiérrez Cívicos, D Gutiérrez-Meca Maestre, I Muñoz García, P Conesa Zamora, A García Márquez, R Guerrero Bautista, MH García Lagunar, E Ferris Villanueva, I Español Morales
Publikováno v:
European Journal of Hospital Pharmacy. 23:A191.2-A191
Background Interindividual variability in treatment response may be associated with the presence of gene polymorphisms. Monoclonal antibodies seem to exert, at least partly, their mechanism of action by inducing apoptosis in antigen expressing cells.
Publikováno v:
European Journal of Hospital Pharmacy. 23:A90.1-A90
Background At discharge of elderly patients, improving reconciliation information and transmission to general practitioners (GP) on therapeutic optimisation is an important issue, especially in relation to potentially inappropriate medications (PIMs)
Publikováno v:
European Journal of Hospital Pharmacy. 23:A61.2-A62
Background The high activity antiretroviral therapy (HAART) should be efficient, safe and facilitate patient adherence. Purpose To analyse immunovirological effectiveness, viral load (VL) and CD4 cells, safety (lipid profile) and adherence to 24 week
Publikováno v:
European Journal of Hospital Pharmacy. 23:A169.2-A169
Background Appropriate drug formulations are essential for efficacy and safety of medicine. Purpose Our aim was to assess the extent of use of extemporaneously prepared/modified products and to assess the age-appropriateness of licensed formulations
Autor:
C Batlle Perales, M Olmo Martinez, I Aguilar Barcons, C Toro Blanch, L Gratacos Santanach, M Vila Currius, R Sacrest Güell
Publikováno v:
European Journal of Hospital Pharmacy. 23:A78.2-A78
Background Some of the commonly used anti-infective drugs have excellent oral (PO) bioavailability. The switch from the intravenous (IV) to the PO route, when it is possible, is one of the antimicrobial stewardship recommendations in order to decreas
Publikováno v:
European Journal of Hospital Pharmacy. 23:A219.2-A219
Background According to legislation, prescription of carbapenems and quinolones should be reduced by 50% by 2020. The Support Programme for Antimicrobial Prescription aims to survey the incidence rate of multi-drug-resistant microorganisms. Purpose T